Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment

被引:44
|
作者
Gurevitch, O [1 ]
Prigozhina, TB [1 ]
Pugatsch, T [1 ]
Slavin, S [1 ]
机构
[1] Hadassah Univ Hosp, Canc Immunotherapy & Canc Immunobiol Res Ctr, Dept Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
关键词
D O I
10.1097/00007890-199911150-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Successful engraftment of hematopoietic stem cells requires a supportive hematopoietic stromal microenvironment (HSM), Defects in the HSM associated with aplastic anemia, myelofibrosis, or caused by intensive ionizing radiation and chemotherapy generally result in failure of bone marrow (BM) engraftment. Transplantation of donor BM within donor HSM may therefore provide optimal conditions for allogeneic BM. transplantation. We have transplanted donor hematopoietic cells together with their own HSM to improve acceptance of allogeneic or xenogeneic BM. The non-myeloablative treatment used induced tolerance to murine allografts and provided conditions for the lifelong acceptance of allogeneic HSM, Allogeneic BM transplanted within it's own HSM under the kidney capsule caused less graft-versus-host disease than BM transplanted i.v. Tolerance in mice to xenogeneic (rat) HSM was less complete. Ectopic ossicles were small and contained fewer hematopoietic cells. However, simultaneous transplantation of rat BM and HSM to preconditioned mice improved engraftment of rat BM compared with transplantation of BM alone. Donor hematopoietic cells survived longer on their own HSM than on HSM of recipients.
引用
收藏
页码:1362 / 1368
页数:7
相关论文
共 50 条
  • [21] Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor
    O Hequet
    J-P Bourgeot
    M Michallet
    E Morelon
    J-M Dubernard
    V Dubois
    B Devauchelle
    Bone Marrow Transplantation, 2008, 41 : 1059 - 1061
  • [22] Hematopoietic and stromal reconstitution after haploidentical allogeneic bone marrow transplantation.
    Tabilio, A
    Aversa, F
    Regazzi, E
    Falzetti, F
    Covalovo, S
    Garau, D
    Rizzoli, V
    Martelli, MF
    Stella, CC
    BLOOD, 1996, 88 (10) : 1042 - 1042
  • [23] Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation
    Petinati, N. A.
    Shipunova, I. N.
    Bigildeev, A. E.
    Kuzmina, L. A.
    Saribekyan, R. A.
    Galtseva, I. V.
    Misyurin, A. V.
    Parovichnikova, E. N.
    Savchenko, V. G.
    Drize, N. I.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 95 - 99
  • [24] ASSESSMENT AND MANAGEMENT OF DONOR PAIN FOLLOWING MARROW HARVEST FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HILL, HF
    CHAPMAN, CR
    JACKSON, TL
    SULLIVAN, KM
    BONE MARROW TRANSPLANTATION, 1989, 4 (02) : 157 - 161
  • [25] DEVELOPMENT OF HYPERTHYROIDISM IN DONOR AND RECIPIENT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ICHIHASHI, T
    YOSHIDA, H
    KIYOI, H
    FUKUTANI, H
    KUBO, K
    YAMAUCHI, T
    NAOE, T
    OHNO, R
    BONE MARROW TRANSPLANTATION, 1992, 10 (04) : 397 - 398
  • [26] LEUKEMIA RELAPSE IN DONOR CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEWBURGER, PE
    LATT, SA
    PESANDO, JM
    GUSTASHAW, K
    POWERS, M
    CHAGANTI, RSK
    OREILLY, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12): : 712 - 714
  • [27] DONOR CELL LEUKEMIA AFTER 17 YEARS OF ALLOGENEIC BONE MARROW TRANSPLANTATION
    Jimenez, P.
    Perez-Alija, A.
    Martinez, M.
    Rodriguez, J.
    Garcia, J., V
    Alvarez, J. C.
    Lorente, J. A.
    Ruiz-Cabello, F.
    Garrido, P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S480 - S480
  • [28] Extramedullary relapse after allogeneic bone marrow transplantation and transfusion of donor lymphocytes
    Werner, A.
    Ufen, M.
    Hayduk, R.
    Schubert, U.
    Kraemer, D.
    Schweiger, C.
    Binarsch, S.
    Koehne, C.
    Casper, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S115 - S115
  • [29] USE OF DONOR ALLOGENEIC CULTURED-CELLS IN BONE-MARROW TRANSPLANTATION
    MAUCH, P
    HAMILTON, B
    LIPTON, J
    HELLMAN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 278 - 278
  • [30] Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation
    Ikpeazu, C
    Davidson, MK
    Halteman, D
    Goodman, SA
    Browning, PJ
    Brandt, SJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 301 - 308